Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study

Botzenhardt S, Felisi M, Bonifazi D, Del Vecchio GC, Putti MC, Kattamis A, Ceci A, Wong ICK, Neubert A (2018)

Publication Type: Journal article

Publication year: 2018

Journal

Haematologica Ferrata Storti Foundation

Book Volume: 103

Pages Range: e1-e4

Journal Issue: 1

DOI: 10.3324/haematol.2017.176065

Authors with CRIS profile

Sebastian Botzenhardt Department of Paediatrics and Adolescent Medicine Antje Neubert Department of Paediatrics and Adolescent Medicine

Involved external institutions

Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) IT Italy (IT) Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari IT Italy (IT) Azienda Ospedaliera di Padova IT Italy (IT) National and Kapodistrian University of Athens GR Greece (GR) University College London (UCL) GB United Kingdom (GB)

How to cite

APA:

Botzenhardt, S., Felisi, M., Bonifazi, D., Del Vecchio, G.C., Putti, M.C., Kattamis, A.,... Neubert, A. (2018). Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study. Haematologica, 103(1), e1-e4. https://doi.org/10.3324/haematol.2017.176065

MLA:

Botzenhardt, Sebastian, et al. "Long-term safety of deferiprone treatment in children from the Mediterranean region with beta-thalassemia major: the DEEP-3 multi-center observational safety study." Haematologica 103.1 (2018): e1-e4.

BibTeX: Download